[1]
Silva, S., Sousa, P., Gonçalves, A.R., Cravo, M., Moura Santos, P., Tavares, L., Valente, A., Correia, L., Serejo, F. and Velosa, J. 2013. Paradoxical adverse events in inflammatory bowel disease patients taking infliximab. Internal Medicine. 20, 3 (Sep. 2013), 105–112.